Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Synthomer PLC Board/Management Information 2021

Mar 12, 2021

4649_mang_2021-03-12_62077309-4fdd-4f2f-acbf-76ac28181b67.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 1619S

Synthomer PLC

12 March 2021

LEI: 213800EHT3TI1KPQQJ56

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Calum MacLean

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Synthomer plc

b)

LEI

213800EHT3TI1KPQQJ56

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

GB0009887422

b)

Nature of the transaction

Grant of nil cost option under the Synthomer Performance Share Plan subject to performance conditions

c)

Price(s) and volume(s)

Price(s) Volume(s)
Nil 261,039

d)

Aggregated information

- Aggregated volume

- Price

261,039

Nil

e)

Date of the transaction

11/03/2021

f)

Place of the transaction

Not applicable

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHEASDAFFDFEFA